• SGI-1027 Induces Apoptosis via DNMT1 Inhibition in Huh7 Cell

  2026-04-22

  This study demonstrates that SGI-1027, a non-nucleoside DNMT inhibitor, induces apoptosis in Huh7 hepatocellular carcinoma cells chiefly through mitochondrial pathways, with minimal cell cycle disruption. The findings highlight the therapeutic potential of DNMT1 inhibition in cancer models and provide a mechanistic framework for future epigenetic therapies.

• ER Stress-Driven Induction of Prometastatic States in Tumors

  2026-04-22

  This study uncovers how tumor cells surviving imminent cell death can transition into stable, prometastatic states through ER stress, reprogramming, and cytokine signaling. The findings illuminate new mechanisms underlying metastatic initiation and highlight potential intervention targets within the tumoral ecosystem.

• IMPDH-Dependent Nucleotide Biosynthesis Fuels PEDV Replicati

  2026-04-21

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) exploits host IMPDH-dependent guanine nucleotide biosynthesis to support its replication. Both genetic and pharmacological inhibition of IMPDH, particularly with Merimepodib (VX-497), sharply reduces viral propagation, establishing IMPDH as a promising host-directed antiviral target.

• FLAG tag Peptide (DYKDDDDK): Precision Tag for Protein Purif

  2026-04-21

  The FLAG tag Peptide (DYKDDDDK) enables highly specific, gentle purification and detection of recombinant proteins. Its unique sequence and enterokinase-cleavage site optimize elution and workflow flexibility. This article details quantitative benchmarks, best-use protocols, and evidence-based limitations, supporting reliable application in molecular biology.

• THZ1: Covalent CDK7 Inhibitor Workflows for Cancer Biology

  2026-04-20

  THZ1, a potent covalent CDK7 inhibitor from APExBIO, unlocks precision transcriptional control and robust antiproliferative effects in cancer models, particularly T-cell acute lymphoblastic leukemia (T-ALL). This article translates recent mechanistic and workflow insights into actionable experimental protocols, troubleshooting guidance, and practical assay enhancements.

• Probenecid for Multidrug Resistance and Neuroprotection Rese

  2026-04-20

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) stands out as a dual-action biochemical tool for overcoming multidrug resistance in tumor models and mitigating neuronal damage in ischemia/reperfusion injury. This guide translates cutting-edge mechanistic evidence and bench-proven workflows into actionable protocols, helping researchers maximize assay integrity and reproducibility.

• Carfilzomib (PR-171) for Proteasome Inhibition in Cancer Ass

  2026-04-19

  Carfilzomib (PR-171) offers bench scientists an irreversible, nanomolar-potency tool for dissecting proteasome-mediated cell death pathways. This guide translates cutting-edge preclinical findings and troubleshooting insights into actionable workflows, helping you optimize apoptosis induction and proteasome inhibition in diverse cancer research contexts.

• AICAR and AMPK: Precision Tools for Macrophage Polarization

  2026-04-18

  Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) uniquely enables targeted AMPK activation to dissect macrophage polarization and inflammation in metabolic disease models. This in-depth review draws on the latest mechanistic evidence and practical assay insights.

• SC 79: Advanced Akt Activation for Neuroprotection & Metabol

  2026-04-17

  Explore how SC 79, a potent Akt activator, enables groundbreaking research in neuroprotection and metabolic disease. This article offers a unique, assay-driven perspective on SC 79’s mechanistic advantages and translational potential.

• CDC42 Regulates HBV Entry via NTCP Trafficking and Macropino

  2026-04-16

  Cui et al. reveal that CDC42, a Rho GTPase, facilitates hepatitis B virus (HBV) entry into hepatocytes through Rab11-dependent NTCP trafficking and by promoting macropinocytosis, independent of the canonical clathrin-mediated pathway. These insights highlight new mechanistic targets for antiviral strategies and deepen our understanding of HBV–host interactions.

• HBV G1896A Mutation Drives HCC Malignancy via ER Stress and

  2026-04-15

  This study reveals that the hepatitis B virus (HBV) precore G1896A mutation promotes hepatocellular carcinoma (HCC) progression by activating ER stress and enhancing aerobic glycolysis. The findings elucidate a mechanistic axis involving PERK-ATF4 signaling and PFKFB3 transcription, highlighting new targets for HCC intervention.

• Angiotensin 1/2 (1-6): Precision Modulation in Cardiovascula

  2026-04-14

  Discover how Angiotensin 1/2 (1-6) empowers advanced renin-angiotensin system research. This article uniquely dissects its molecular selectivity and recent virology intersections, offering evidence-based guidance for cardiovascular and renal assay optimization.

• WZ4003 (SKU B1374): Reliable NUAK1/2 Inhibition for Cell Ass

  2026-04-13

  This article delivers scenario-driven guidance for optimizing cell viability and proliferation assays with WZ4003 (SKU B1374), a highly selective NUAK1/2 inhibitor. Drawing on recent peer-reviewed data and practical workflow experience, it addresses protocol optimization, data interpretation, and vendor reliability, enabling researchers to achieve reproducible, high-sensitivity results in cancer and neurodegeneration research.

• Phenacetin in Advanced Pharmacokinetic Studies: Protocol & P

  2026-04-13

  Phenacetin (N-(4-ethoxyphenyl)acetamide) is a benchmark probe for human-relevant pharmacokinetic studies, now empowered by state-of-the-art hiPSC-derived intestinal organoid models. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and evidence-driven tips for maximizing assay reliability with APExBIO's high-purity Phenacetin.

• Dual-Action Kinase Inhibitors Modulate p38α MAPK Dephosphory

  2026-04-12

  The reference study reveals that certain kinase inhibitors, including those targeting p38α MAPK, not only block kinase activity but also promote its dephosphorylation by altering activation loop conformation. This dual-action mechanism provides a new strategy to enhance specificity and potency in inflammation and cytokine signaling research.

14617 records 1/975 page Next 12345 下5页 Last page